Leukocyte depletion for safe blood transfusion

Biotechnology Journal

Volumn 4, Issue 8, 2009, Pages 1140-1151

  Singh, Shikha ^a   Kumar, Ashok ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

Blood transfusion; HLA proteins; Leukocyte depletion; Leukocyte depletion filters; Leukocyte mediated adverse reactions

Indexed keywords

BLOOD TRANSFUSION; HLA PROTEINS; LEUKOCYTE DEPLETION; LEUKOCYTE DEPLETION FILTERS; LEUKOCYTE-MEDIATED ADVERSE REACTIONS;

BLOOD; CELL MEMBRANES; CENTRIFUGATION; CYTOLOGY; DIELECTRIC PROPERTIES; POROUS MATERIALS; PROTEINS; SIZE SEPARATION;

PLATELETS;

HLA ANTIGEN;

AFFINITY CHROMATOGRAPHY; ALLOIMMUNIZATION; BASOPHIL; BLOOD FILTRATION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CELL SELECTION; CENTRIFUGATION; CREUTZFELDT JAKOB DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIELECTRIC CONSTANT; DISEASE TRANSMISSION; EOSINOPHIL; ERYTHROCYTE; FEBRILE NONHEMOLYTIC TRANSFUSION REACTION; FILTRATION; FREEZE THAWING; HUMAN; LEUKOPENIA; NEUTROPHIL; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VIRUS INFECTION;

BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; BLOOD TRANSFUSION; CELL SEPARATION; CENTRIFUGATION; CREUTZFELDT-JAKOB SYNDROME; EQUIPMENT DESIGN; FILTRATION; HLA ANTIGENS; HUMANS; LEUKOCYTES; REPERFUSION INJURY; SAFETY; VIRUSES;

EID: 70350123021     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200800182     Document Type: Review

References (59)

1. Ampofo, W., Trebi, N. N., Ansah, J., Abe, K. et al., Prevalence of blood-borne infectious diseases in blood donors in Ghana. J. Clin Microbiol. 2002, 40, 3523-3525.
2. Seidl, S.,Kuhnl, P.,Transmission of diseases by blood transfusion. World J. Surg. 1987, 11, 30-35.
3. Sethu, P., Sin, A., Toner, M., Microfluidic diffusive filter for apheresis (leukapheresis). Lab Chip 2006, 6, 83-89.
4. Roenhorst, H.W., Kallenberg, G. M., The, T. H., The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts:Development and maintenance of CMV-latency and its influence on immunocompetence. Clin. Exp. Immunol. 1988, 74, 326-332.
5. Frohn, C., Fricke, L., Puchta, J. C., Kirchner, H., The effect of HLA-C matching on acute renal transplant rejection. Nephrol. Dial. Transplant. 2001, 16, 355-360.
6. Vamvakas, E. C.,The case against universal white blood cell reduction. ISBT Sci. Series 2006, 1, 64-72.
7. Sawa, Y., Matsuda, H., Shimazaki, Y., Kaneko, M. et al., Evaluation of leucocyte depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 1994, 108, 1125-1131.
8. Dellinger, E. P., Anaya, D. A., Infectious and immunologic consequences of blood transfusion. Crit. Care 2004, 8, 18-23.
9. Carson, J. L., Berlin, J. A., Will we ever know if leukoreduction of red cells should be performed. Can. J. Anesth. 2004, 51, 407-411.
10. Obara, S., Iwama, H., Prestorage leukocyte reduction prevents the formation of microaggregates that occlude artificial capillary vessels. J. Crit. Care 2004, 19, 179-186.
11. Hyllner, M., Prestorage leucocyte filtration of blood: Effects on cytokine generation and complement activation. Curr. Anaesth. Crit. Care 2004, 15, 95-100.
12. Chapman, J. F., Forman, K., Kelsey, P., Knowles, S. M., Guidelines on the clinical use of leukocyte-depleted blood components. Transfus. Med. 1998, 8, 59-71.
13. Vries, A. J. D., Gu, D.Y.J., Oeveren, W.V., The clinical effects and mechanisms of leukocyte depletion filters during cardiac surgery. Ann. Cardiac Anaesth. 2005, 8, 117-124.
14. Bordin, J.O., Heddle, N. M., Blajchman, M.A., Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994, 84, 1703-1721.
15. Pruss, A., Kalus, U., Radtke, H., Koscielny, J. et al., Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus. Apheresis Sci. 2004, 30, 41-46.
16. Chu, R.W., Leukocytes in blood transfusion:Adverse effects and their prevention. HKMJ 1999, 5, 280-284.
17. Ezidiegwu, C. N., Lauenstein, K. J., Rosales, L. G., Kelly, K. C. et al., Febrile nonhemolytic transfusion reactions. Arch. Pathol. Lab. Med. 2004, 128, 991-995.
18. Kooy, M. V. M., Prooijen, H. C. V., Moes, M., Stants, L. B., Akkerman, J.W. N., Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial. Blood 1991, 77, 201-205.
19. Seftel, M. D., Growe, G. H., Petraszko, T., Benny, W. B. et al., Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 2004, 103, 333-339.
20. h1-type dominant response. Int. Immunol. 2001, 13, 785-790.
21. Deborah, P., Sower, L., Allison, P., Kurosky, A. et al., Leukocyte reduction, plasma apheresis, and cytomegalovirus dna levels in samples. Lab. Med. 2007, 38, 676-679.
22. Glenn, J., Cytomegalovirus infections following renal transplantation. Rev. Infect. Dis. 1981, 3, 1151-1178.
23. Bowden, R. A., Slichter, S. J., Sayers, M., Weisdorf, D. et al., A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995, 86, 3598-3603.
24. Patel, A. N., Sutton, S.W., Livingston, S., Patel, A. et al., Clinical benefits of leukocyte filtration during valve surgery. Am. J. Sur. 2003, 186, 636-640.
25. Warren, O., Alexiou, C., Massey, R., Leff, D. et al., The effects of various leukocyte filtration strategies in cardiac surgery. Eur. J. Cardiothorac. Surg. 2007, 31, 665-676.
26. Ardehali, A., Laks, H., Russell, H., Levine, M. et al., Modified reperfusion and ischemia-reperfusion injury in human lung transplantation. J. Thorac. Cardiovasc. Surg. 2003, 126, 1929-1934.
27. Bohmova, R., Viklicky, O., Renal ischemia-reperfusion injury: An inescapable event affecting kidney transplantation outcome. Folia Microbiol. 2001, 46, 267-276.
28. Lefer, A. M., Campbell, B., Scalia, R., Lefer, D. J., Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: Role of selectins. Circulation 1998, 98, 1322-1328.
29. Lim, H. K., Anderson, J., Leong, J. Y., Pepe, S. et al., What is the role of leukocyte depletion in cardiac surgery? Heart Lung Circul. 2007, 16, 243-253.
30. Sakamoto, Y., Wei, L. H., Buckberg, G. D., Youg, H. H., Effects of leukocyte-depleted reoxygenation on endothelial and ventricular function: With observation of a short time period. Ann. Thorac. Cardiovasc. Surg. 2002, 8, 343-349.
31. Johnston, L., Conly, J., Creutzfeldt-Jakob disease and infection control. Can. J. Infect Dis. 2001, 12, 332-336.
32. Will, R., New variant Creutzfeldt-Jakob disease, Biomed. Pharmacother. 1999, 53, 9-13.
33. Will, R. G., Ironside, J.W., Zeidler, M. et al., A new variant of Creutzfeldt-Jakob disease in UK. Lancet 1996, 347, 921-925.
34. Gregori, L., McCombie, N., Palmer, D., Birch, P. et al., Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 2004, 264, 529-531.
35. Robertson, C., Booth, S. A., Beniac, D. R., Coulthart, M. B. et al., Cellular prion protein is released on exosomes from activated platelets. Blood 2006, 107, 3907-3911.
36. Karger GmbH (Freiburg), Safety of blood and blood products with regard to vCJD. Transfus. Med. Hemother. 2006, 33, 13-17.
37. Yang, J., Huang, Y., Wang, X. B., Becker, F. F., Gascoyne, P. R. C., Differential analysis of human leukocytes by dielectrophoretic field-flow-fractionation. Biophy J. 2000, 78, 2680-2689.
38. Kumar, A., Plieva, F. M., Galaev, I.Y., Mattiasson, B., Affinity fractionation of lymphocytes using a monolithic cryogel. J. Immunol. Methods 2003, 283, 185-194.
39. Han, K. H., Frazier, A. B., Paramagnetic capture mode magnetophoretic microseparator for blood cells. IEE Proc. Nanobiotechnol. 2006, 153, 67-73.
40. Furlani, E. P., Magnetophoretic separation of blood cells at the microscale. J. Phys. D: Appl. Phys. 2007, 40, 1313-1319.
41. Zborowski, M., Ostera, G. R., Moore, L. R., Milliron, S. et al., Red blood cell magnetophoresis, Biophys. J. 2003, 84, 2638-2645.
42. Farrugia, A., Shea, N., Knowles, S., Holdsworth, R. et al., Cryopreservation of red blood cells: Effect of freezing on red cell quality and residual lymphocyte immunogenicity. J. Clin. Pathol. 1993, 46, 742-745.
43. Loos, J. A., Wautier, J. L., Leukocyte depletion: A biotechnical transfusion story. Transfus. Clin. Biol. 1998, 5, 64-79.
44. Pasqualetti, D., Ghirardini, A., Arista, M. C., Vaglio, S. et al., Blood component fractionation: Manual versus automatic procedures. Transfus. Apheresis Sci. 2004, 30, 23-28.
45. Sharma, A. D., Sreeram, G., Erb, T., Grocott, H. P. et al., Leukocyte-reduced blood transfusions: Perioperative indications, adverse effects, and cost analysis. Anesth. Analg. 2000, 90, 1315-1323.
46. Vries, A. J. D., Thesis: Aspects of leucocyte and fat filtration during cardiac surgery. University of Groningen, The Netherlands, 2005.
47. Rijn, C. V., Nijdam, W., Elwenspoek, M., A microsieve for leukocyte depletion of erythrocyte concentrates. 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Amsterdam 1996, 1. 6. 1: Microfabrication.
48. Cencic, A., Koren, S., Filipic, B., Stropnik, C., Porcine blood cell separation by porous cellulose acetate membranes. Cytotechnology 1998, 26, 165-171.
49. Kova, M. J., Bartunkova, J., Smetana, K., Lukas, J. et al., Comparative study of human monocyte and platelet adhesion to hydrogels in vitro - Effect of polymer structure. J. Mater. Sci. Mater. Med. 1997, 8, 19-23.
50. Henschler, R., Ruster, B., Steimle, A., Hansmann, H. L. et al., Analysis of leukocyte binding to depletion filters: Role of passive binding, interaction with platelets, and plasma components. Ann Hematol. 2005, 84, 538-544.
51. Elias, M. K., Smit, J.W., Weggemans, M., Rijskamp, L. et al., In vitro evaluation of a high-efficiency leukocyte adherence filter. Ann. Hematol. 1991, 63, 302-306.
52. Dvorak, L., Pirk, J., Cerny, S., Kovar, J., The role of leukocyte depleting filters in heart transplantation: early outcomes in prospective, randomized clinical trial. Eur. J. Cardiothorac. Surg. 2006, 30, 621-627.
53. Phelan, H. A., Sperry, J. L., Friese, R. S., Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients. J. Surg. Res. 2007, 138, 32-36.
54. Lewis, A. L., Freeman, R. N.T., Redman, R. P., Tolhurst, L.A. et al., Wettable phosphorylcholine-containing polymers useful in blood filtration. J. Mater. Sci. Mater. Med. 2003, 14, 39-45.
55. Natori, S. H., Kurita, K., Blood cell separation using amphiphilic copolymers containing N,N-dimethylacrylamide. J. Biomed. Mater. Res. Part B Appl. Biomater. 2007, 81, 419-426.
56. Guidance for Industry Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion, U. S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research January, 2001.
57. Circular of Information for the Use of Human Blood and Blood Components. American Association of Blood Banks, America's Blood Centers, American Red Cross, August 2000.
58. Schuetz, A. N., Hillyer, K. L., Roback, J. D., Hillyer, C. D., Leukoreduction filtration of blood with sickle cell trait. Transfus. Med. Rev. 2004, 18, 168-176.
59. Krailadsiri, P., Gilcher, R., Seghatchian, J., Leukoreduction of sickle cell trait blood an unresolved issue. Transfus. Apheresis Sci. 2001, 24, 223-225.